Chronic inflammation in visceral adipose tissue (VAT) precipitates the development of cardiometabolic disorders. Although changes in T cell function associated with visceral obesity are thought to affect chronic VAT inflammation, the specific features of these changes remain elusive. Here, we have determined that a high-fat diet (HFD) caused a preferential increase and accumulation of CD44 hi CD62L lo CD4 + T cells that constitutively express PD-1 and CD153 in a B cell-dependent manner in VAT. These cells possessed characteristics of cellular senescence and showed a strong activation of Spp1 (encoding osteopontin [OPN]) in VAT. Upon T cell receptor stimulation, these T cells also produced large amounts of OPN in a PD-1-resistant manner in vitro. The features of CD153 + PD-1 + CD44 hi CD4 + T cells were highly reminiscent of senescence-associated CD4 + T cells that normally increase with age. Adoptive transfer of CD153 + PD-1 + CD44 hi CD4 + T cells from HFD-fed WT, but not Spp1-deficient, mice into the VAT of lean mice fed a normal diet recapitulated the essential features of VAT inflammation and insulin resistance. Our results demonstrate that a distinct CD153 + PD-1 + CD44 hi CD4 + T cell population that accumulates in the VAT of HFD-fed obese mice causes VAT inflammation by producing large amounts of OPN. This finding suggests a link between visceral adiposity and immune aging.
Introduction
Visceral obesity is associated with chronic low-grade inflammation in visceral adipose tissue (VAT) and a sustained whole-body proinflammatory state, which may underlie metabolic and cardiovascular diseases (1) (2) (3) (4) (5) (6) . VAT inflammation associated with obesity involves a complex network of responses of immune cell components, including acquired immune cells such as various subsets of T cells and B cells and innate immune cells such as macrophages (7) (8) (9) (10) . Among these cells, CD4 + T cells have been recognized as a central regulator of chronic VAT inflammation (9) (10) (11) (12) (13) (14) . The number of CD4 + T cells in VAT increases as the tissue expands in obesity. Factors that drive CD4 + T cell expansion and differentiation into proinflammatory effectors in VAT during the development of high-fat diet-induced (HFD-induced) obesity may include MHC class II-associated antigens, possibly self-peptides, because the T cell receptor (TCR) repertoire of CD4 + T cells in VAT is limited, and deficiency of MHC class II protects mice from HFD-induced VAT inflammation and insulin resistance (11, (14) (15) (16) . For instance, IFN-γ-producing Th1 cells enhance proinflammatory macrophage activation (12) (13) (14) 17) , and IL-17 produced by Th17 cells may cause insulin resistance by affecting insulin receptor signaling (18) . By contrast, IL-4-and IL-13-secreting Th2 cells and FoxP3 + Tregs suppress VAT inflammation by inducing antiinflammatory macrophages that secrete . However, the obesityassociated immune background underlying chronic inflammation in VAT remains elusive.
Significant changes occur in the overall T cell populations with age. In CD4 + T cells, proportions of naive (CD44 lo CD62L hi ) cells sharply decline in ontogeny, with an age-dependent increase in cells of the memory phenotype (CD44 hi CD62L lo ) (22, 23) . Among CD44 hi CD4
+ T cells, a unique population expressing programmed cell death 1 (PD-1) and CD153 actually increases with age in mice (20) . PD-1 is a negative costimulatory receptor for TCR signaling (24) , and CD153 is a TNF superfamily protein (25) 
CD4
+ T cell population shows compromised proliferation and regular T cell cytokine production on T cell receptor (TCR) stimulation but secretes large amounts of proinflammatory cytokines, such as osteopontin (OPN). These CD4 + T cells also show signatures of cell senescence, including a marked increase in senescence-related gene expression and nuclear heterochromatin foci, and are termed senescence-associated T cells (SA-T cells) (9) . Notably, the age-dependent development of SA-T cells, which may include autoreactive cells, is dependent on B cells (9) . As such, the increase in SA-T cells is suggested to be involved in part in immune aging phenotypes such as impaired acquired Chronic inflammation in visceral adipose tissue (VAT) precipitates the development of cardiometabolic disorders. Although changes in T cell function associated with visceral obesity are thought to affect chronic VAT inflammation, the specific features of these changes remain elusive. Here, we have determined that a high-fat diet (HFD) caused a preferential increase and accumulation of CD44 
+ T cell population that accumulates in the VAT of HFD-fed obese mice causes VAT inflammation by producing large amounts of OPN. This finding suggests a link between visceral adiposity and immune aging. 6 Miho Sekai, er than those in ND-fed mice as early as 2 weeks after initiation of the HFD and progressively increased thereafter ( Figure 1A) . Notably, the VAT CD4 + T cells from 18-week-old HFD-fed mice showed an increasing shift in the proportions of naive CD44 
+ T cells were remarkably higher than those in age-matched ND-fed mice (Figure 2A ). Immunostaining analysis confirmed that PD-1 + T cells were localized in CLSs of HFD-fed obese mice, but they were rarely detected in those of ND-fed lean mice (Figures 2B 
+ T cells showed significantly less production of IL-2 and IFN-γ upon TCR stimulation than did PD-1 −
+ cells ( Figure 3A) , which was consistent with diminished expression of special AT-rich sequence-binding protein 1 (Satb1), a crucial gene for T cell cytokine activation (28, 29) , and increased expression of CCAAT/enhancer-binding protein α (Cebpa), which is normally expressed in myeloid cell lineages (30) ( Figure 3B ). However, the VAT PD-1
+ T cells secreted remarkably large amounts of OPN via TCR stimulation, whereas the PD-1 − fraction did so minimally ( Figure 3C ). HFD-fed mice consistently showed significantly increased serum OPN levels (Figure immune capacity, increased proinflammatory traits, and high risk for autoimmunity (26) .
In the present study, we demonstrate that CD153 + PD-1 + CD44 hi CD4 + T cells are remarkably increased and preferentially accumulated in the VAT of HFD-fed mice in a B cell-dependent manner and that these CD4 + T cells show functional and genetic features strongly resembling SA-T cells that increase in secondary lymphoid tissues with age. We also indicate that the CD153
+ T cells play a crucial role in inducing chronic VAT inflammation and metabolic disorder via secretion of large amounts of OPN.
Results

A HFD induces an increase and accumulation of PD-
+ T cells in VAT. C57BL/6 (B6) mice were fed an HFD starting at 4 weeks of age. By 18 weeks of age, these mice had an increased BW and visceral fat mass, glucose intolerance, and insulin resistance compared with age-matched B6 mice fed a normal diet (ND) (Supplemental Figure 1, A Figure  1 , C and D). These macrophages were localized in crown-like structures (CLSs) (Supplemental Figure 1E) , representing typical obesity-associated chronic inflammation of VAT (17, 27) . VAT of 18-week-old HFD-fed obese mice showed increased proportions of CD4 + T cells in total T cell infiltrates ( Figure 1A ). The absolute numbers of CD4 + T cells per gram of VAT were significantly high- 
CD4
+ T cells predominantly accumulated in VAT, although they also appeared in much lower numbers in spleen, liver, and subcutaneous adipose tissue (SAT) and negligibly in blood ( Figure 5D ). In VAT, CD153 + T cells were confirmed to be localized in CLSs ( Figure 5E ). These results indicated that CD153 Figure 4C ; see also Figure 2A ). In contrast, this cell population remained negligible in VAT from ND-fed mice at least until 18 + T cells in VAT in an unsynchronized manner over a given time period, whereas the Spp1 gene may be activated constitutively to a much lesser extent in VAT macrophages. The PD-1 receptor plays an important role in resolving inflammation by negatively regulating T cell activation upon interaction with the ligands (35) (36) (37) (38) . We found that adipocytes, macrophages, and B cells, the major antigen-presenting cells in VAT (11, 16, 39) , strongly expressed programmed cell death ligand 1 (PD-L1) in HFD-fed mice ( Figure 7A + T cells after an HFD (n = 5 mice per group). Flow cytometric plots are representative of at least 3 independent experiments. Data represent the mean ± SEM. *P < 0.05, **P < 0.001, and ***P < 0.0001, by 2-tailed Student's t test. Figure 10B ). In agreement with these findings and consistent with those of a previous report (16), HFD-fed μMT mice showed significantly milder glucose intolerance and insulin resistance than did age-matched HFD-fed WT mice ( Figure  11A ), although the degrees of weight gain and fat deposition were unchanged ( Figure 11B ). HFD-fed μMT mice also had assuredly reduced expression of Spp1, Ifng, and Tnfa ( Figure 11C ) as well as resistance, strongly suggesting that these unique CD4 + T cells play a substantial role in initiating VAT inflammation and metabolic disorder in HFD-fed mice.
OPN has been reported to be increased in the circulating blood of obese diabetic and insulin-resistant patients (42, 48) and to play a causative role in VAT inflammation and insulin resistance (19, 49) . Using EGFP-Spp1-KI reporter mice, we demonstrated that a significant proportion of CD153 
+ T cells was hardly affected by PD-1 signaling, suggesting that the activation of these T cells in VAT is not under checkpoint control and allows the chronic progression of VAT inflammation.
Although our study focused on a unique CD4 + T cell subpopulation in VAT of HFD-fed obese mice, we found that the numbers a compromised increase in CD11c hi CD206
lo macrophages in VAT compared with HFD-fed WT mice ( Figure 11D ) and lower levels of OPN in plasma ( Figure 11E ). These results suggest that B cells play a crucial role in the robust increase of CD153 
Discussion
Various types of immune cells have been identified in VAT, and visceral obesity influences the proliferation and function of these immune cells (7) (8) (9) (10) . In the current study, we found that a unique subset of CD44 + T cells. The vast majority of these T cells also showed a markedly increased expression of SA-β-gal, γ-H2AX, and Cdkn1a/Cdkn2b, with reduced Satb1 expression, suggestive of cellular senescence. Spp1 activation in Th1 cells is regulated by T-bet, and deregulated OPN production induces excessive Th1 polarization (46) . In addition, T-bet-deficient mice show suppressed proinflammatory immune cell infiltration in VAT and improved glucose homeostasis compared with WT mice (47) . It remains to be seen whether the skewed production of large amounts of OPN is due to excessive Th1 polarization or reflects a feature of cellular senescence, namely SA-secretory phenotypes (31) . In any case, these T cells were remarkably increased in the VAT of HFD-fed mice, although essentially similar T cells were also detected in much smaller numbers in spleen.
We demonstrated that adoptive transfer of CD153 resistance against infection (8), chronic low-grade inflammation (53, 54) , and a greater susceptibility to autoimmunity (55) . It has been suggested that the increase in CD153 + SA-T cells in chronological aging and systemic autoimmunity is attributable to a robust, homeostatic T cell proliferation (31) , but the precise mechanism underlying the accumulation of these T cells in VAT of HFD-fed mice remains to be investigated. Nonetheless, it is an intriguing possibility that the predisposition often associated with obesity may partly be a systemic manifestation of the premature increase in CD153 + SA-T cells in VAT, since adipose tissues can constitute up to 50% to 60% of total BW in severe obesity (7) .
In conclusion, we have demonstrated that a unique subpopulation of CD4 + T cells expressing PD-1 and CD153 plays an important role in VAT inflammation and insulin resistance under HFD conditions through OPN production. The current results underof CD8 + cells were also significantly increased in VAT of ND-fed mice, with a marked B cell-dependent predominance of CD44 hi CD62L lo cells. However, these CD8 + T cells expressed very little CD153, nor did they show activation of the Spp1 gene. Thus, we hypothesize that CD8 + T cells show different features and behave in different ways from CD4 + T cells in HFD-fed VAT. Their exact features remain to be investigated and will be the subject of future research by our group.
It is noteworthy that CD153 + SA-T cells may partly underlie the immune aging, including a reduction in acquired immunity and an increase in the inflammatory trait and autoimmunity risk (26, 52) . Obesity is also associated with diminished 
Methods
Animal work. C57BL/6 (B6) mice were purchased from Japan SLC Inc., and μMT, Spp1-KO, and EGFP-Spp1-KI reporter mice were described before (31) . All mice were housed under a 12-hour light/12-hour dark cycle and allowed free access to food. Mice were fed with either a ND (CE-2, 6 kcal % fat; CLEA Japan Inc.) or an HFD (D12492, 60 kcal% fat; Research Diets Inc.). We used littermate controls in the experiments involving Spp1-KO and EGFP-Spp1-KI reporter mice on a B6 background. B6 mice were used as a control for μMT mice (which were purchased from The Jackson Laboratory), according to The Jackson Laboratory's recommendation.
Isolation of the stromal vascular fraction and flow cytometry. We isolated stromal vascular cells using previously described methods, + T cells versus vehicle (n = 10 mice per group). Data represent the mean ± SEM. *P < 0.05 and ***P < 0.0001, by ANOVA followed by post hoc Bonferroni tests jci.org Volume 126 Number 12 December 2016 ratories) for 1 hour. Tissue samples were excited using 4 wavelengths (405, 488, 568, and 800 nm) and the emission collected through the appropriate narrow band-pass filters on a confocal microscope (LSM 510 META; Carl Zeiss). The images were acquired and processed using LSM 510 software (Carl Zeiss).
Quantitative real-time PCR. Total RNA samples from sorted cells and VAT were prepared using an RNeasy Mini Kit (QIAGEN) or TRIzol reagent (Invitrogen, Thermo Fisher Scientific) according to the manufacturers' instructions. A First-Strand cDNA Synthesis Kit (Invitrogen, Thermo Fisher Scientific) was used for cDNA synthesis. Quantitative real-time PCR was performed using the ABI PRISM 7700 Sequence Detection System (Applied Biosystems) or the ViiA 7 Real-Time PCR System (Thermo Fisher Scientific). The Gapdh gene was used as an endogenous control to normalize for differences in the amount of total RNA in each sample. All values were expressed as a fold increase or decrease relative to the expression of Gapdh. The primer sequences for genes were as follows: Gapdh, 5′-AGGTCGGTGTGAACGGATTTG and 3′-TGTAGACCATGTAGTTGAGGTCA; Spp1, 5′-CCCGGT-GAAGTGCTGATT and 3′-TTCTTCAGAGGACACAGCATTC; Ifng, 5′-ATCTGGAGGAACTGGCAAAA and 3′-TTCAAGACTTCAAA-GAGTCTGAGG; Cebpa, 5′-TGAGAAAAATGAAGGGTGCAG and 3′-CGGGATCTCAGCTTCCTGT; Satb1, 5′-ACTGAAACGAGCCG-GAATC and 3′-CGGAGGATTTCAGAAAGCAA; Tnfa, 5′-CCCTCA-CACTCAGATCATCTTCT and 3′-GCTACGACGTGGGCTACAG; Eef1a1, 5′-CAACATCGTCGTAATCGGACA and 3′-GTCTAAGAC-CCAGGCGTACTT; Dusp10, 5′-CCATCTCCTTTAGACGACAG-GG and 3′-GCTACCACTACCTGGGCTG; Emr1, 5′-TTGTACGT-GCAACTCAGGACT and 3′-GATCCCAGAGTGTTGATGCAA; Pparg, 5′-TCGCTGATGCACTGCCTATG and 3′-GAGAGGTCThe Abs used were specific to CD3 (14A-2; BioLegend); CD4 (GK1.5; BioLegend); CD8a (53-6.7 and OKT8; eBioscience); CD44 (IM7; BioLegend); CD62L (MEL-14; eBioscience); CD11b (M1/70; eBioscience); F4/80 (BM8; BioLegend); CD11c (N418; eBioscience); CD206 (MR5D3; Biolegend); PD-1 (RMP1-30 and 29F.1A12; BioLegend); CD45 (30F11.1; eBioscience); CD19 (1D3; eBioscience); PD-L1 (10F.9G2; BioLegend); CD153 (RM153; BioLegend); GL7 (GL7; BioLegend); and 7-AAD viability staining solution (BioLegend). We analyzed intracellular cytokine production with a Cytofix/Cytoperm Fixation/Permeabilization Solution Kit (BD Pharmingen) and a transcriptional factor using a True-Nuclear Transcription Factor Buffer Set (BioLegend). The Abs used were specific to FoxP3 (FJK-16s; eBioscience); T-bet (4B10; BioLegend); GATA3 (16E10A23; BioLegend); RORγt (B2D; eBioscience); and γ-H2AX (N1-431; BD Pharmingen).
IHC. Whole-mount VAT was stained and visualized. Mice were sacrificed by cervical dislocation, after which VAT was removed using sterile technique and minced into small pieces (~2-3 mm) using a scalpel. Tissue pieces were washed, fixed in cellFIX (catalog 340181; BD) for 60 minutes, and permeabilized with 0.1% Triton X-100 for 10 minutes. The specimens were then blocked with 5% BSA and incubated with primary Abs specific to CD3 (145-2C11; BD); PD-1 (J43; Bio X Cell); F4/80 (BM-8; eBioscience); and CD153 (RM153; eBioscience) for 1 hour and then with Alexa Fluor 488-and 647-conjugated secondary Abs (Molecular Probes, Thermo Fisher Scientific) for 1 hour. The tissues were counterstained for 1 hour with BODIPY 558/568 (Molecular Probes, Thermo Fisher Scientific) to visualize adipocytes and with DAPI (Molecular Probes, Thermo Fisher Scientific) to visualize nuclei. The vasculature was stained with Griffonia simplicifolia B4 isolectin conjugated with Alexa Fluor 488 (FL-1201; Vector Labo- ) were purified by positive selection using anti-CD19 MACS Beads (Miltenyi Biotec) according to the manufacturer's instructions and were generally more than 95% CD19 + B220 + . B cells were cultured in DMEM supplemented with 10% FBS plus LPS from Escherichia coli (1 μg/ml; Sigma-Aldrich) in the presence or absence of recombinant OPN for 72 hours. We used 3 mice per sample of the cells.
ELISA. The levels of OPN (R&D Systems); IFN-γ (BioLegend); IL-17 (R&D Systems); and total IgG (eBioscience) in supernatants or serum were determined by ELISA according to the manufacturers' instructions.
Migration of peritoneal macrophages. We isolated 1 × 10 5 PD-1 − , CD153 − PD-1 + , and CD153 + PD-1 + CD4 + T cells from VAT of HFD-FED WT mice. We used 5-7 mice per sample of the cells. These cells were cultured in complete RPMI with immobilized anti-CD3 mAb (5 μg/ ml) and soluble anti-CD28 mAb (2.5 μg/ml). After 120 hours of culture, the culture medium was aspirated and analyzed by a migration assay using Boyden chambers with 8-mm pore inserts (BD). Peritoneal macrophages were cultured in the upper wells, and the conditioned medium was added to the lower wells. We used fresh DMEM supplemented with 5% FBS as a control. To inhibit OPN activity, an anti-OPN Ab (2 μg/ml; Sigma-Aldrich) or control IgG was added to the conditioned medium. + T cells were sorted from VAT or spleens of WT mice fed an HFD. These were stimulated with 5 μg/ml plate-bound anti-CD3 with anti-OPN Ab (2 μg/ml; Sigma-Aldrich) or control IgG and mixed with B cells at a 1:3 T cell/B cell ratio in U-bottomed 96-well plates. We used 5-7 mice per sample of the indicated cells (Supplemental Figure 5D ). Ten days later, the total IgG concentration of the supernatants was determined by ELISA (eBioscience). T cell culture. CD4 + T cells or CD8 + T cells (1 × 10 5 ) were stimulated with immobilized anti-CD3 mAb (5 μg/ml) with soluble anti-CD28 mAb (2.5 μg/ml) in the presence or absence of 1 μg/ml mouse recombinant OPN for 72 hours. We used 5-7 mice per sample of the cells. PD-L1-Ig or control IgG (R&D Systems) was additionally included in the culture. hi macrophage ratios between WT and μMT mice fed an HFD (n = 6 mice per group). (E) Comparison of serum OPN concentrations between WT and μMT mice fed an HFD (n = 6 mice per group). Data represent the mean ± SEM. *P < 0.05, **P < 0.001, and ***P < 0.0001, by 2-tailed Student's t test.
